Bid Publish Date
10-Mar-2025, 3:44 pm
Bid End Date
31-Mar-2025, 4:00 pm
EMD
₹22,120
Value
₹7,37,195
Location
Progress
RAQuantity
495
Bid Type
Two Packet Bid
Indian Air Force has released a public tender for Mumps Measles Rubella MMR, Hepatitis A vaccine Live attenuated, Diptheria Tetanus and Acellular Pertusis vaccine DTaP, Fractional IPV FIPV 2 point 5 ml vial, Human Papilloma virus quadrivalent Types 6 coma 11 coma 16 coma 18 vaccine Recombinant PFS of 0 point 5 ml in Rangareddi, TELANGANA. Quantity: 495. Submission Deadline: 31-03-2025 16: 00: 00. Download documents and apply online.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Mumps Measles Rubella MMR , Hepatitis A vaccine Live attenuated , Diptheria Tetanus and Acellular Pertusis vaccine DTaP , Fractional IPV FIPV 2 point 5 ml vial , Human Papilloma virus quadrivalent Types 6 coma 11 coma 16 coma 18 vaccine Recombinant PFS of 0 point 5 ml
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Mumps Measles Rubella MMR
Vaccine
Hepatitis A vaccine Live attenuated
Vaccine
Diptheria Tetanus and Acellular Pertusis vaccine DTaP
Vaccine
Fractional IPV FIPV 2 point 5 ml vial
Vaccine
Human Papilloma virus quadrivalent Types 6 coma 11 coma 16 coma 18 vaccine Recombinant PFS of 0 point 5 ml
Vaccine
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Mumps Measles Rubella MMR | Vaccine | 90 | no | 14afh@proc | 45 | |
| 2 | Hepatitis A vaccine Live attenuated | Vaccine | 45 | no | 14afh@proc | 45 | |
| 3 | Diptheria Tetanus and Acellular Pertusis vaccine DTaP | Vaccine | 105 | no | 14afh@proc | 45 | |
| 4 | Fractional IPV FIPV 2 point 5 ml vial | Vaccine | 150 | no | 14afh@proc | 45 | |
| 5 | Human Papilloma virus quadrivalent Types 6 coma 11 coma 16 coma 18 vaccine Recombinant PFS of 0 point 5 ml | Vaccine | 105 | pfs | 14afh@proc | 45 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
30-Apr-2025, 3:00 pm
End
01-May-2025, 3:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ACTSOCPRO ENVIRONMENT SOLUTIONS LLP Under PMA | - | 27-03-2025 16:45:07 | |
| 2 | HINDUSTAN MARCHANTS Under PMA | - | 27-03-2025 10:54:18 | |
| 3 | SRI GANESH PHARMACY Under PMA | - | 30-03-2025 11:37:30 | |
| 4 | SUNIL PHARMACY Under PMA | - | 31-03-2025 10:25:47 | |
| 5 | VANSH ENTERPRISES Under PMA | - | 31-03-2025 12:49:15 |
These are the final prices after the reverse auction event. Prices may be lower than initial bids.
| Rank | Seller | Final Price | Item |
|---|---|---|---|
| L1 | SRI GANESH PHARMACY(MSE) Under PMA Winner | ₹4,46,655 | Item Categories : Mumps Measles Rubella MMR,Hepatitis A vaccine Live attenuated,Diptheria Tetanus and Acellular Pertu |
| L2 | ACTSOCPRO ENVIRONMENT SOLUTIONS LLP (MSE,MII) Under PMA | ₹6,93,000 | Item Categories : Mumps Measles Rubella MMR,Hepatitis A vaccine Live attenuated,Diptheria Tetanus and Acellular Pertu |
| L3 | VANSH ENTERPRISES (MSE,MII) Under PMA | ₹7,40,025 | Item Categories : Mumps Measles Rubella MMR,Hepatitis A vaccine Live attenuated,Diptheria Tetanus and Acellular Pertu |
| L4 | SUNIL PHARMACY (MSE) Under PMA | ₹8,17,500 | Item Categories : Mumps Measles Rubella MMR,Hepatitis A vaccine Live attenuated,Diptheria Tetanus and Acellular Pertu |
🎉 L1 Winner
SRI GANESH PHARMACY(MSE) Under PMA
Final Price: ₹4,46,655
Key insights about TELANGANA tender market
The eligibility requirements include being a registered entity authorized to supply vaccines and meeting all regulatory qualifications. Bidders must prove past experience in supplying similar products to government or military bodies. The entity should have necessary certifications guaranteeing vaccine quality and safety.
To successfully place a bid, entities must provide certificates such as a valid business registration, certifications from health authorities, and other relevant documentation that validates compliance with vaccine safety and efficacy standards.
The registration process requires bidders to create an account on the designated procurement portal. Once registered, they can access the tender documents and submit their bids electronically, ensuring adherence to all outlined requirements and specifications.
The technical specifications for the vaccines mandate adherence to WHO guidelines and local health authority regulations. They should meet specific shelf-life criteria, alongside stringent packaging and labeling requirements to ensure safe transport and usage.
The evaluation process will focus on several key aspects, including technical compliance, financial viability, and the bidder's previous performance. The selection will prioritize bids that demonstrate competitive pricing while meeting all specifications and requirements outlined in the tender documentation.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS